Jean-Luc Brun
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Jean-Luc Brun has a total of 277 co-authors. Here are the top co-authors by number of shared publications:
- Cyrille Huchon
APHP. Service de gynécologie & obstétrique, GH Saint-Louis Lariboisière-Fernand Widal, Hôpital Lariboisière, Université de Paris, 2, rue Ambroise Paré, 75010 Paris, France
4 shared publications H. Marret
Service de chirurgie pelvienne gynécologique et oncologique, hôpital Bretonneau, CHRU Tours, 2 boulevard Tonnellé, 37044 Tours, France
4 shared publicationsA. Torre
Centre de procréation médicalement assistée, centre hospitalier Sud Francilien, 40 avenue Serge Dassault, 91106 Corbeil-Essonnes, France
3 shared publicationsC. Huchon
Service de gynécologie-obstétrique, hôpital Lariboisière, AP-HP, 2 rue Ambroise Paré, 75010 Paris, France
3 shared publicationsG. Dubernard
Service de gynécologie, hôpital Croix Rousse, CHU Lyon, 103 grande rue de la Croix-Rousse, 69004 Lyon, France
3 shared publicationsG. Legendre
Service de gynécologie-obstétrique, CHU Angers, 4 rue Larrey, 49933 Angers, France
3 shared publications
Latest Publications
- Open Access
- 17 July 2025
- Published by Elsevier in Gynécologie Obstétrique Fertilité & Sénologie
- Vol. 53 (9) , 365-489
Le cancer du col de l’utérus : recommandations pour la pratique clinique
- 17 July 2025
- Published by Elsevier in Gynécologie Obstétrique Fertilité & Sénologie
- Vol. 53 (9) , 365-489
Open AccessLe cancer du col de l’utérus : recommandations pour la pratique clinique
- 21 January 2024
- Published by Elsevier in Journal of Gynecology Obstetrics and Human Reproduction
- Vol. 53 (3) , 102727
Percutaneous cryoablation of symptomatic uterine adenomyomas: Initial experience
- 21 January 2024
- Published by Elsevier in Journal of Gynecology Obstetrics and Human Reproduction
- Vol. 53 (3) , 102727
Percutaneous cryoablation of symptomatic uterine adenomyomas: Initial experience
- 13 July 2022
- Published by Elsevier in Journal of Gynecology Obstetrics and Human Reproduction
- Vol. 51 (8) , 102442
Regression of cervical high-grade squamous intraepithelial lesions (HSIL/CIN2) managed expectantly
- 13 July 2022
- Published by Elsevier in Journal of Gynecology Obstetrics and Human Reproduction
- Vol. 51 (8) , 102442
Regression of cervical high-grade squamous intraepithelial lesions (HSIL/CIN2) managed expectantly
- 28 June 2022
- Published by Elsevier in Gynécologie Obstétrique Fertilité & Sénologie
- Vol. 50 (10) , 650-656
Satisfaction après mastectomie de réduction de risque associée à une reconstruction chez les patientes porteuses d’une mutation génétique
- 28 June 2022
- Published by Elsevier in Gynécologie Obstétrique Fertilité & Sénologie
- Vol. 50 (10) , 650-656
Satisfaction après mastectomie de réduction de risque associée à une reconstruction chez les patientes porteuses d’une mutation génétique
- 4 March 2022
- Published by Elsevier in Gynécologie Obstétrique Fertilité & Sénologie
- Vol. 50 (5) , 345-373
Prise en charge des ménorragies : recommandations pour la pratique clinique du Collège national des gynécologues et obstétriciens français (CNGOF)
- 4 March 2022
- Published by Elsevier in Gynécologie Obstétrique Fertilité & Sénologie
- Vol. 50 (5) , 345-373
Prise en charge des ménorragies : recommandations pour la pratique clinique du Collège national des gynécologues et obstétriciens français (CNGOF)
- 1 February 2022
- Published by Elsevier in Gynécologie Obstétrique Fertilité & Sénologie
- Vol. 50 (2) , 130-135
Recommandations pour la pratique clinique du CNGOF : évaluation un an après révision de la méthodologie
- 1 February 2022
- Published by Elsevier in Gynécologie Obstétrique Fertilité & Sénologie
- Vol. 50 (2) , 130-135
Recommandations pour la pratique clinique du CNGOF : évaluation un an après révision de la méthodologie
- 11 November 2020
- Published by Springer Nature in Archives of Gynecology and Obstetrics
- Vol. 303 (4) , 1065-1073
Factors predicting the spontaneous regression of cervical high-grade squamous intraepithelial lesions (HSIL/CIN2)
Purpose To determine clinical, pathological and virological factors predicting the spontaneous regression of HSIL/CIN2. Methods This retrospective study included 73 patients with HSIL/CIN2 diagnosed by biopsy between 2012 and 2016 and followed-up without treatment in the department of gynecology at Bordeaux University Hospital. All biopsies sampled inside or outside our department were reviewed and immunolabelled for p16 and Ki67. The response rate was the regression or the disappearance of HSIL/CIN2 as defined by the regression or the disappearance of initial colposcopic findings, cytological and/or histological results. Results The diagnosis of CIN2 was confirmed in 63 of 70 biopsies available for review. The Cohen’s kappa coefficient was κ = 90%, indicating almost perfect inter-observer agreement. The lesion spontaneously regressed or disappeared in 36 of 60 patients (60%) with confirmed CIN2 during a median follow-up of 20 months (range 6–55). Baseline factors influencing the response rate were colposcopic findings (69% with minor change vs 31% with major change, p = 0.033), cytological results (72% with ASCUS/LSIL vs 28% with ASC-H/HSIL, p = 0.018), and HPV genotyping (71% with HPV not 16 vs 42% with HPV-16, p = 0.027). The other factors (age, smoking, surface area of the lesion, p16 and Ki67 expressions) did not significantly influence the outcome. Conclusion Colposcopic findings, cytological results, and HPV genotyping were baseline factors predicting spontaneous regression of HSIL/CIN2.
- 11 November 2020
- Published by Springer Nature in Archives of Gynecology and Obstetrics
- Vol. 303 (4) , 1065-1073
Factors predicting the spontaneous regression of cervical high-grade squamous intraepithelial lesions (HSIL/CIN2)
Purpose To determine clinical, pathological and virological factors predicting the spontaneous regression of HSIL/CIN2. Methods This retrospective study included 73 patients with HSIL/CIN2 diagnosed by biopsy between 2012 and 2016 and followed-up without treatment in the department of gynecology at Bordeaux University Hospital. All biopsies sampled inside or outside our department were reviewed and immunolabelled for p16 and Ki67. The response rate was the regression or the disappearance of HSIL/CIN2 as defined by the regression or the disappearance of initial colposcopic findings, cytological and/or histological results. Results The diagnosis of CIN2 was confirmed in 63 of 70 biopsies available for review. The Cohen’s kappa coefficient was κ = 90%, indicating almost perfect inter-observer agreement. The lesion spontaneously regressed or disappeared in 36 of 60 patients (60%) with confirmed CIN2 during a median follow-up of 20 months (range 6–55). Baseline factors influencing the response rate were colposcopic findings (69% with minor change vs 31% with major change, p = 0.033), cytological results (72% with ASCUS/LSIL vs 28% with ASC-H/HSIL, p = 0.018), and HPV genotyping (71% with HPV not 16 vs 42% with HPV-16, p = 0.027). The other factors (age, smoking, surface area of the lesion, p16 and Ki67 expressions) did not significantly influence the outcome. Conclusion Colposcopic findings, cytological results, and HPV genotyping were baseline factors predicting spontaneous regression of HSIL/CIN2.